Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(2.78)
# 1,989
Out of 5,090 analysts
5
Total ratings
60%
Success rate
34.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma | Initiates: Buy | $4 | $0.55 | +628.86% | 1 | Aug 25, 2025 | |
| IRD Opus Genetics | Initiates: Buy | $5 | $2.27 | +120.26% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $17.56 | +36.67% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $1.20 | +400.00% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $4.37 | +197.48% | 1 | Dec 17, 2024 |
Cue Biopharma
Aug 25, 2025
Initiates: Buy
Price Target: $4
Current: $0.55
Upside: +628.86%
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $2.27
Upside: +120.26%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $17.56
Upside: +36.67%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $1.20
Upside: +400.00%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $4.37
Upside: +197.48%